(1) The Executive Director may cancel a commercial evaluation authorisation for the introduction of an industrial chemical if the Executive Director is not satisfied that the risks to human health or the environment from the introduction and use of the industrial chemical can be managed.
(2) The Executive Director must give written notice of the proposed cancellation, and the reasons for the cancellation, to each holder of the authorisation.
(3) The holder of the authorisation may make a written submission to the Executive Director about the proposed cancellation.
(4) A submission must be given within the period specified in the notice, which must not be less than 20 working days after the day the notice is given.
(5) After considering any submissions made during that period, the Executive Director must decide to:
(a) cancel the commercial evaluation authorisation; or
(b) not cancel the commercial evaluation authorisation.
(6) The Executive Director must give written notice of the decision to each holder of the authorisation.